16-hydroxycleroda-3,13(14)-dien-15,16-olide has been researched along with Kidney Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, YC; Chia, YC; Huang, BM; Lee, WC; Liu, C | 1 |
1 other study(ies) available for 16-hydroxycleroda-3,13(14)-dien-15,16-olide and Kidney Neoplasms
Article | Year |
---|---|
16-Hydroxycleroda-3, 13-dien-15, 16-olide inhibits the proliferation and induces mitochondrial-dependent apoptosis through Akt, mTOR, and MEK-ERK pathways in human renal carcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Diterpenes; Humans; Kidney Neoplasms; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mitochondria; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; TOR Serine-Threonine Kinases | 2017 |